
Adjuvant Anlotinib Displays Efficacy in High-Grade Soft Tissue Sarcoma
Adjuvant treatment with anlotinib decreased the risk of disease recurrence compared with surgery alone for the treatment of patients with completely resected localized, high-grade soft tissue sarcoma, according to data from a phase 2 trial (NCT03951571) …